Navigation Links
Dorset County Hospital Enhances MRSA Surveillance Programme Through Rapid Patient Screening
Date:11/4/2008

Dorset County Hospital screens elective and Orthopaedic admissions patients in only 75 minutes using Cepheid's advanced Xpert(TM) MRSA technology

DORSET, England, Nov. 4 /PRNewswire/ -- Dorset County Hospital (DCH) is working hard to reduce MRSA infections and, as part of that plan, has introduced enhanced MRSA surveillance. As part of the programme, DCH is screening all elective and orthopaedic admissions for MRSA. Screening enables hospitals to identify patients who carry the bacteria on their skin or nasal passages, i.e. colonised patients. This is important because MRSA bacteria can be easily transmitted from patient to patient and can lead to serious infections. Previously, screening technology took at least 24 hours by a process of growing the bacteria on culture plates. The Xpert(TM) MRSA test, which runs on Cepheid's GeneXpert(R) System, delivers DNA-based results in 75 minutes. This new rapid technology means DCH has enough time to identify colonised patients and make immediate decisions based on patient needs.

Dorset's MRSA Surveillance Programme includes:

-- Pre-surgical screening of all elective and orthopaedic admissions

-- Isolation of positive patients

-- Appropriate treatment for colonised patients prior to and during

surgery

Alison Tong, Director of Nursing and Infection Prevention and Control, says, "We are always looking for new ways to further prevent infection and improve patient care. Xpert MRSA rapid screening technology will vastly reduce the risks to patients admitted to Dorset County Hospital and I hope will provide further reassurance to the public that we are continually striving to minimise all risks to patients. It is so easy-to-use that we are now considering training non-laboratory technical staff to undertake some screening."

It has been estimated that about 5 in 100 people carry MRSA bacteria on their skin. In fact, the Health Protection Agency reported 1,805 infected patients within the UK from January to June 2008. The bacteria can enter the body through open wounds, injections, catheters and IV sites making in-hospital patients extremely susceptible to infection. People with weak immune systems are also more prone to the illnesses brought on by the bacteria, including blood poisoning, organ infection and lung infection. Owing to the risk carriers pose to themselves and other patients, the Department of Health has actually set out guidance for all elective patients to be screened by March 2009.

About Dorset County Hospital

Dorset County Hospital in Dorchester offers a full range of district general services, including an accident and emergency department, diabetic service and renal service. They are the main provider of acute hospital services to around 210,000 people living in Weymouth and Portland, West Dorset, North Dorset and Purbeck. DCH was recently rated "Excellent" by the Healthcare Commission for its quality of services and has also been rated one of the top trusts in England for reducing cases of MRSA.

About the GeneXpert(R) System Molecular Diagnostic Platform

The GeneXpert(R) System is a closed, self-contained, fully-integrated and automated platform that represents a paradigm shift in the automation of molecular analysis, producing accurate results in a timely manner with minimal risk of contamination. The GeneXpert(R) System is the only system to combine on-board sample preparation with real-time PCR (polymerase chain reaction) amplification and detection functions for fully integrated and automated nucleic acid analysis. The system is designed to purify, concentrate, detect and identify targeted nucleic acid sequences thereby delivering answers directly from unprocessed samples. Modular in design, the GeneXpert(R) System has a variety of configurations to meet the broad range of testing demands of any clinical environment.

For further information, please contact:

Nigel Smith/Laura Warner/Victoria Harvey

Schwartz Communications

E: cepheidUK@schwartz-pr.co.uk

T: 020 7268 3028


'/>"/>
SOURCE Dorset County Hospital
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Netsmart Technologies Selected by City and County of San Francisco to Provide Integrated Behavioral Healthcare Software System
2. BNBI Employees Donate 1,000 Backpacks to Frederick County School Children
3. China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province
4. China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County, Guangxi Province
5. MedImmunes Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
6. First-Ever Cancer and Careers Seminar Debuts in Orange County
7. Ventria Receives Friends of Education Award From Geary County School District
8. CryoLife to Present at Roth Capital Partners 20th Annual Orange County (OC) Growth Stock Conference
9. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
10. Mediatech Moves to Prince William County Innovation Park
11. Memorial Medical First in Stanislaus County to Provide Convertible Ultrasound From ZONARE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Summit for ... to support the development of a patient-specific stem cell therapy for the treatment of ... lab of Dr. Jeanne Loring at The Scripps Research Institute in San Diego, CA. ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... support for Connecticut's innovative, growing companies, today announced the launch of VentureClash ... technology (fintech) companies. , “VentureClash looks to attract the best early-stage ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... technology at the Spring 2016 Marijuana Business Conference and Expo. Shimadzu’s high-performance instruments ... heavy metals, and more. Expo attendees can stop by booth 1021 to learn ...
(Date:4/27/2016)... British Virgin Islands (PRWEB) , ... April 27, ... ... Holding Company Ltd. (d/b/a Biohaven) is pleased to announce the appointment of John Tilton ... he was an Executive Director and one of the founding commercial leaders responsible ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):